Moderna Inc. is experiencing a significant surge in its stock price, driven by positive market sentiment and bullish setups.
Moderna Inc. (NASDAQ:MRNA) is rising today, with shares up by 8.50% to close at CA$167.14. This impressive gain comes amid a broader market rally, where several stocks are entering buy areas.
Advertisement
Moderna Inc
MRNA.US
MRNA.US
Moderna Inc
WealthAwesomeMarket cap
$58.14B
52W high
$176.66
52W low
$22.28
1W change
+7.38%
Beta
1.11
Analyst Price Targets
Based on 27 analysts covering MRNA · as of Sep 17, 2026
Wall Street analysts forecast MRNA stock price to fall 17.9% over the next 12 months.
Consensus
Hold3.22 / 5.00
Avg. Target
C$119.56
-17.9% Upside
Current Price
C$145.62
Last close
Analyst Breakdown (27 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MRNA's historical volatility
30-Day Vol
315.3%
Annualized
90-Day Vol
223.3%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$184.16
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$163.49 | C$55.09 – C$485.15 |
| 60 trading days | C$173.51 | C$37.26 – C$807.98 |
| 90 trading days | C$184.16 | C$27.99 – C$1211.70 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should take note of Moderna's strong performance and consider the potential for further gains, especially given the bullish sentiment surrounding its recent developments.
8.50% Gain
Moderna's stock has shown a remarkable 8.50% increase today, reflecting strong buying interest.
Bull case
The recent surge is due to renewed investor confidence after the company released promising Phase 3 data on its mRNA-based cancer therapy. This therapy has the potential to be a blockbuster, thanks to its large addressable market.
Bear case
Despite the positive momentum, there are concerns about overall market conditions and potential volatility. These factors could pose risks for investors looking to enter at this stage.
Market Sentiment Boosts Moderna
Advertisement
The stock market has shown mixed action recently, but Moderna's strong performance stands out. Analysts have noted that the stock is entering a buy zone, attracting attention from investors looking for growth opportunities.
Bullish Setups Indicate Potential Growth
Moderna's recent price action suggests a bullish setup, with the stock forming a high-tight flag pattern. This technical formation often indicates that a stock is poised for further gains, making it an attractive option for investors.
Future Prospects and Investor Considerations
While the current momentum is promising, investors should remain cautious of potential market volatility. Keeping an eye on Moderna's developments, particularly in its cancer therapy pipeline, will be crucial for assessing future investment decisions.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
